The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Oral Treatment Targeting the Unfolded Protein Response Prevents Neurodegeneration and Clinical Disease in Prion-Infected Mice
Abstract
During prion disease, an increase in misfolded prion protein (PrP) generated by prion replication leads to sustained overactivation of the branch of the unfolded protein response (UPR) that controls the initiation of protein synthesis. This results in persistent repression of translation, resulting in the loss of critical proteins that leads to synaptic failure and neuronal death. We have previously reported that localized genetic manipulation of this pathway rescues shutdown of translation and prevents neurodegeneration in a mouse model of prion disease, suggesting that pharmacological inhibition of this pathway might be of therapeutic benefit. We show that oral treatment with a specific inhibitor of the kinase PERK (protein kinase RNA-like endoplasmic reticulum kinase), a key mediator of this UPR pathway, prevented UPR-mediated translational repression and abrogated development of clinical prion disease in mice, with neuroprotection observed throughout the mouse brain. This was the case for animals treated both at the preclinical stage and also later in disease when behavioral signs had emerged. Critically, the compound acts downstream and independently of the primary pathogenic process of prion replication and is effective despite continuing accumulation of misfolded PrP. These data suggest that PERK, and other members of this pathway, may be new therapeutic targets for developing drugs against prion disease or other neurodegenerative diseases where the UPR has been implicated.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In fact, the oral administration of highly selective PERK inhibitors significantly reduces neurodegeneration and clinical disease in prion-infected mice, crossing the BBB efficiently [402,403].”
From GANAB and N-Glycans Substrates Are Relevant in Human Physiology, Polycystic Pathology and Multiple Sclerosis: A Review (2022) · cites this paper as [402]
Citations
Cites
1 retracted
Atkin, J. D., Farg, M. A., Walker, A. K., McLean, C., Tomas, D., & Horne, M. K. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.02.009 · Cited by 350
RetractedSignal integration in the endoplasmic reticulum unfolded protein response
Ron, D., & Walter, P. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2199 · Cited by 6,431
Regulated Translation Initiation Controls Stress-Induced Gene Expression in Mammalian Cells
Harding, H. P., Novoa, I., Zhang, Y., Zeng, H., Wek, R. C., Schapira, M., & Ron, D. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00108-8 · Cited by 3,344
Adapting Proteostasis for Disease Intervention
Balch, W. E., Morimoto, R. I., Dillin, A., & Kelly, J. W. (2008) · Science · doi:10.1126/science.1141448 · Cited by 2,495
Harding, H. P., Zeng, H., Zhang, Y., Jungries, R., Chung, P., Plesken, H., Sabatini, D. D., & Ron, D. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00264-7 · Cited by 1,217
Depleting Neuronal PrP in Prion Infection Prevents Disease and Reverses Spongiosis
Mallucci, G. R., Dickinson, A., Linehan, J. M., Klöhn, P., Brandner, S., & Collinge, J. (2003) · Science · doi:10.1126/science.1090187 · Cited by 783
Self-citationTranslational Regulation of Gene Expression during Conditions of Cell Stress
Spriggs, K. A., Bushell, M., & Willis, A. E. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.09.028 · Cited by 748
Self-citationAxten, J. M., Medina, J. R., Feng, Y., Shu, A. Y. L., Romeril, S. P., Grant, S. W., Li, W. H. H., Heerding, D. A., Minthorn, E. A., Mencken, T., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300713s · Cited by 620
Self-citationSustained translational repression by eIF2α-P mediates prion neurodegeneration
Moreno, J. A., Radford, H. E., Peretti, D., Steinert, J. R., Verity, N., Martin, M. G., Halliday, M., Morgan, J., Dinsdale, D. D., Ortori, C. A., et al. (2012) · Nature · doi:10.1038/nature11058 · Cited by 616
Self-citationThe Unfolded Protein Response Is Activated in Pretangle Neurons in Alzheimer's Disease Hippocampus
Hoozemans, J. J. M., van Haastert, E. S., Nijholt, D. A. T., Rozemuller, A. J. M., Eikelenboom, P., & Scheper, W. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.080814 · Cited by 600
Cited by
Sorted by citations
Items 301–400 of 582
Wen, L., Xiao, B., Shi, Y., & Han, F. (2017) · APOPTOSIS · doi:10.1007/s10495-017-1371-5 · Cited by 28
Abhishek, K., Das, S., Kumar, A., Kumar, A., Kumar, V., Saini, S., Mandal, A., Verma, S., Kumar, M., & Das, P. K. (2018) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0006646 · Cited by 28
Hughes, D. T., Halliday, M., Smith, H., Verity, N., Molloy, C., Radford, H. E., Butcher, A. J., & Mallucci, G. R. (2020) · Science Signaling · doi:10.1126/scisignal.abb4749 · Cited by 27
Self-citationThe key roles of organelles and ferroptosis in Alzheimerʼs disease
Long, H., Cheng, Y., Zhou, Z., Luo, H., Wen, D., & Gao, L. (2022) · Journal of Neuroscience Research · doi:10.1002/jnr.25033 · Cited by 28
PERK prevents rhodopsin degradation during retinitis pigmentosa by inhibiting IRE1-induced autophagy
Zhao, N., Li, N., & Wang, T. (2023) · The Journal of Cell Biology · doi:10.1083/jcb.202208147 · Cited by 27
Jiang, X., Wei, Y., Zhang, T., Zhang, Z., Qiu, S., Zhou, X., & Zhang, S. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.6418 · Cited by 27
Fujii, T., Fujita, N., Suzuki, S. O., Tsuji, T., Takaki, T., Umezawa, K., Watanabe, K., Miyamoto, T. K., Horiuchi, K., Matsumoto, M., et al. (2017) · Journal of Orthopaedic Research® · doi:10.1002/jor.23787 · Cited by 27
Majd, R., Mayeli, M., & Rahmani, F. (2020) · Metabolic Brain Disease · doi:10.1007/s11011-020-00600-8 · Cited by 27
Chen, K., Morizawa, Y. M., Nuriel, T., Al‐Dalahmah, O., Xie, Z., & Yang, G. (2025) · Neuron · doi:10.1016/j.neuron.2025.04.027 · Cited by 27
Risen, S. J., Boland, S. W., Sharma, S., Weisman, G. M., Shirley, P. M., Latham, A. S., Hay, A. J. D., Gilberto, V. S., Hines, A. D., Brindley, S. M., et al. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00846 · Cited by 27
Self-citationChemical probes targeting epigenetic proteins: Applications beyond oncology
Ackloo, S. Z., Brown, P. J., & Müller, S. (2017) · Epigenetics · doi:10.1080/15592294.2017.1279371 · Cited by 27
Liu, M., Shi, G., Zhou, A., Rupert, C. E., Coulombe, K. L. K., & Dudley, S. C. (2018) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2018.02.011 · Cited by 26
PERK Inhibition Mitigates Restenosis and Thrombosis
Wang, B., Zhang, M., Urabe, G., Huang, Y., Chen, G., Wheeler, D. G., Dornbos, D., Huttinger, A., Nimjee, S. M., Gong, S., et al. (2020) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2019.12.005 · Cited by 26
The GRP78-PERK axis contributes to memory and synaptic impairments in Huntington's disease R6/1 mice
Espina, M., Franco, N. D., Brañas-Navarro, M., Rodríguez-Navarro, I., Brito, V., López-Molina, L., Costas‐Insua, C., Guzmán, M., & Ginés, S. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106225 · Cited by 25
Small Molecules and Alzheimer’s Disease: Misfolding, Metabolism and Imaging
Patel, V., Zhang, X., Tautiva, N., Nyabera, A., Owa, O., Baidya, M., Sung, H., Taunk, P., Abdollahi, S., Charles, S., et al. (2015) · Current Alzheimer Research · doi:10.2174/1567205012666150504145646 · Cited by 25
Therapeutic Approaches Targeting Proteostasis in Kidney Disease and Fibrosis
Chen, J.-H., Wu, C.-H., & Chiang, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168674 · Cited by 25
A New PERKspective on Neurodegeneration
Scheper, W., & Hoozemans, J. J. M. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3007641 · Cited by 24
Cuanalo-Contreras, K., & Moreno‐González, I. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20194666 · Cited by 26
Rankovic, M., & Zweckstetter, M. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.12.014 · Cited by 25
van Ziel, A. M., Largo‐Barrientos, P., Wolzak, K., Verhage, M., & Scheper, W. (2019) · Scientific Reports · doi:10.1038/s41598-018-38146-6 · Cited by 24
Decoding Parkinson’s Disease Pathogenesis: The Role of Deregulated mRNA Translation
Martin, I. (2016) · Journal of Parkinson’s Disease · doi:10.3233/jpd-150738 · Cited by 23
Nutraceutical regulation of miRNAs involved in neurodegenerative diseases and brain cancers
Ghosh, S., Kumar, V., Mukherjee, H., Debrupa Lahiri, A., & Roy, P. (2021) · Heliyon · doi:10.1016/j.heliyon.2021.e07262 · Cited by 23
Cognitive Enhancers (Nootropics). Part 2: Drugs Interacting with Enzymes. Update 2014
Froestl, W., Muhs, A., & Pfeifer, A. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-140402 · Cited by 24
Lin, P., Liu, H., Chang, C., Chen, Y.-C., Chang, C., & Shih, W. (2015) · APOPTOSIS · doi:10.1007/s10495-015-1085-5 · Cited by 23
Beckelman, B. C., Day, S. M., Zhou, X., Donohue, M., Gouras, G. K., Klann, E., Keene, C. D., & Ma, T. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160036 · Cited by 29
Prion protein and prion disease at a glance
Zhu, C., & Aguzzi, A. (2021) · Journal of Cell Science · doi:10.1242/jcs.245605 · Cited by 27
Chen, K., Hu, Q., Gupta, R., Stephens, J., Xie, Z., & Yang, G. (2022) · Aging Cell · doi:10.1111/acel.13592 · Cited by 22
Prion-induced and spontaneous formation of transmissible toxicity in PrP transgenic Drosophila
Thackray, A. M., Di, Y., Zhang, C., Wolf, H., Pradl, L., Vorberg, I. M., Andréoletti, O., & Bujdoso, R. (2014) · Biochemical Journal · doi:10.1042/bj20140129 · Cited by 22
Abhishek, K., Sardar, A. H., Das, S., Kumar, A., Ghosh, A. K., Singh, R., Saini, S., Mandal, A., Verma, S., Kumar, A., et al. (2016) · Molecular and Cellular Biology · doi:10.1128/mcb.00344-16 · Cited by 22
Shao, Z., Wu, P., Wang, X., Mei-shan, J., Liu, S., Ma, X., & Shi, H. (2018) · Neurochemical Research · doi:10.1007/s11064-018-2581-0 · Cited by 22
Rozpędek‐Kamińska, W., Pytel, D., Popławski, T., Walczak, A., Gradzik, K., Wawrzynkiewicz, A., Wojtczak, R., Mucha, B., Diehl, J. A., & Majsterek, I. (2019) · Current Alzheimer Research · doi:10.2174/1567205016666190228121157 · Cited by 22
Intraneuronal tau aggregation induces the integrated stress response in astrocytes
Batenburg, K. L., Kasri, N. N., Heine, V. M., & Scheper, W. (2022) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjac071 · Cited by 21
Capturing the conversion of the pathogenic alpha-1-antitrypsin fold by ATF6 enhanced proteostasis
Sun, S., Wang, C., Zhao, P., Kline, G. M., Grandjean, J. M. D., Jiang, X. J., Labaudinière, R. F., Wiseman, R. L., Kelly, J. W., & Balch, W. E. (2023) · Cell chemical biology · doi:10.1016/j.chembiol.2022.12.004 · Cited by 21
Therapeutic Potential of Targeting the PERK Signaling Pathway in Ischemic Stroke
Yu, X., Dang, L., Zhang, R., & Yang, W. (2024) · Pharmaceuticals · doi:10.3390/ph17030353 · Cited by 22
The role of the unfolded protein response in arrhythmias
Liu, M., & Dudley, S. C. (2018) · Channels · doi:10.1080/19336950.2018.1516985 · Cited by 21
Baron, D. M., Matheny, T., Lin, Y., Leszyk, J., Kenna, K. P., Gall, K. V., Santos, D. P., Tischbein, M., Funes, S., Hayward, L. J., et al. (2019) · Human Molecular Genetics · doi:10.1093/hmg/ddz048 · Cited by 22
Perk Ablation Ameliorates Myelination in S63del-Charcot–Marie–Tooth 1B Neuropathy
Musner, N., Sidoli, M., Zambroni, D., Carro, U. D., Ungaro, D., D’Antonio, M., Feltri, M., & Wrabetz, L. (2016) · ASN Neuro · doi:10.1177/1759091416642351 · Cited by 21
De Masi, R., & Orlando, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137373 · Cited by 20
“In fact, the oral administration of highly selective PERK inhibitors significantly reduces neurodegeneration and clinical disease in prion-infected mice, crossing the BBB efficiently [402,403].”
BackgroundPotential Therapeutic Use of Stem Cells for Prion Diseases
Zayed, M., Kook, S., & Jeong, B. (2023) · Cells · doi:10.3390/cells12192413 · Cited by 21
De Novo Prion Aggregates Trigger Autophagy in Skeletal Muscle
Joshi-Barr, S., Bett, C. K., Chiang, W.-C. J., Trejo, M., Goebel, H. H., Sikorska, B., Liberski, P. P., Raeber, A. J., Lin, J. H., Masliah, E., et al. (2013) · Journal of Virology · doi:10.1128/jvi.02279-13 · Cited by 20
Wang, H., Dou, S., Zhu, J., Shao, Z., Wang, C., & Cheng, B. (2020) · Peptides · doi:10.1016/j.peptides.2020.170374 · Cited by 20
Nna1 gene deficiency triggers Purkinje neuron death by tubulin hyperglutamylation and ER dysfunction
Li, J., Snyder, E. Y., Tang, F. H. F., Pasqualini, R., Arap, W., & Sidman, R. L. (2020) · JCI Insight · doi:10.1172/jci.insight.136078 · Cited by 20
Otero, A., Betancor, M., Eraña, H., Fernández‐Borges, N., Lucas, J. J., Badiola, J. J., Castilla, J., & Bolea, R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22010465 · Cited by 20
Shimizu, T., Higashijima, Y., Kanki, Y., Nakaki, R., Kawamura, T., Urade, Y., & Wada, Y. (2021) · Science Signaling · doi:10.1126/scisignal.abb3616 · Cited by 20
Targeting the unfolded protein response in heart diseases
Liu, M., & Dudley, S. C. (2014) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2014.918605 · Cited by 20
Treatment of Prion Disease with Heterologous Prion Proteins
Skinner, P. J., Kim, H. O., Bryant, D. N., Kinzel, N. J., Reilly, C., Priola, S. A., Ward, A. E., Goodman, P. A., Olson, K. E., & Seelig, D. M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0131993 · Cited by 19
Mercado, G., & Hetz, C. A. (2017) · Brain · doi:10.1093/brain/awx107 · Cited by 19
Shah, S. Z. A., Zhao, D., Taglialatela, G., Khan, S. H., Hussain, T. A., Dong, H., Lai, M., Zhou, X., & Yang, L. (2017) · Neurotherapeutics · doi:10.1007/s13311-016-0500-0 · Cited by 18
RetractedZhou, Y., Liu, J., Xue, P., & Zhang, J. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15102503 · Cited by 18
Yu, Z.-Z., Xu, B.-Q., Wang, Y.-Y., Zhang, P.-W., Shu, Y.-B., & Shi, Z. (2023) · Biomedicines · doi:10.3390/biomedicines11113103 · Cited by 18
Dametto, P., Lakkaraju, A. K., Bridel, C., Villiger, L., O’Connor, T., Herrmann, U., Pelczar, P., Rülicke, T., McHugh, D., Adili, A., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0117412 · Cited by 18
Almost a century of prion protein(s): From pathology to physiology, and back to pathology
Peggion, C., Bertoli, A., & Sorgato, M. C. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.07.118 · Cited by 18
Charif, S. E., Luchelli, L., Vila, A., Blaustein, M., & Igaz, L. M. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.594561 · Cited by 18
Mounier, N. M., Wahdan, S. A., Gad, A. M., & Azab, S. S. (2021) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-021-02081-7 · Cited by 18
RetractedHabib, P., Stamm, A.-S., Schulz, J., Reich, A., Slowik, A., Capellmann, S., Huber, M., & Wilhelm, T. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20215421 · Cited by 17
Translation dysregulation in neurodegenerative disorders
Bosco, D. A. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1818493115 · Cited by 17
Protein aggregate formation permits millennium-old brain preservation
Petzold, A., Lu, C., Groves, M., Gobom, J., Zetterberg, H., Shaw, G., & O’Connor, S. (2020) · Journal of The Royal Society Interface · doi:10.1098/rsif.2019.0775 · Cited by 17
Yodsanit, N., Shirasu, T., Huang, Y., Li, Y., Islam, Z. H., Gregg, A. C., Riccio, A. M., Tang, R., Kent, E. W., Wang, Y., et al. (2023) · Bioactive Materials · doi:10.1016/j.bioactmat.2023.02.009 · Cited by 16
Consequences of mutations in the genes of the ER export machinery COPII in vertebrates
Lu, C., & Kim, J. (2020) · Cell Stress and Chaperones · doi:10.1007/s12192-019-01062-3 · Cited by 16
Sephin1 Reduces Prion Infection in Prion-Infected Cells and Animal Model
Thapa, S., Abdelaziz, D. H., Abdulrahman, B., & Schätzl, H. M. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-01880-y · Cited by 16
Proteostasis: Bad news and good news from the endoplasmic reticulum
Noack, J., Pisoni, G. B., & Molinari, M. (2014) · Swiss Medical Weekly · doi:10.4414/smw.2014.14001 · Cited by 15
Wiersma, V. I., Hecke, W. V., Scheper, W., van Osch, M., Hermsen, W. J. M., Rozemüller, A. J. M., & Hoozemans, J. J. M. (2016) · Acta Neuropathologica Communications · doi:10.1186/s40478-016-0383-7 · Cited by 15
Review: Protein misfolding diseases – the rare case of Marinesco‐Sjögren syndrome
Chiesa, R., & Sallese, M. (2019) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12588 · Cited by 15
Ho-Tieng, D., Sharma, V. K., Sonenberg, N., Gkogkas, C. G., & Khoutorsky, A. (2025) · Trends in Neurosciences · doi:10.1016/j.tins.2025.08.002 · Cited by 14
Duan, J. (2015) · Neuroscience Bulletin · doi:10.1007/s12264-014-1488-2 · Cited by 14
Schneider, B., Baudry, A., Pietri, M., Alleaume‐Butaux, A., Bizingre, C., Nioche, P., Kellermann, O., & Launay, J. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.660683 · Cited by 15
Integrated Stress Response in Neuronal Pathology and in Health
Korneeva, N. L. (2022) · Biochemistry (Moscow) · doi:10.1134/s0006297922140103 · Cited by 14
Kuribara, T., & Totani, K. (2022) · Biology · doi:10.3390/biology11020199 · Cited by 14
Targeting the Unfolded Protein Response as a Disease-Modifying Pathway in Dementia
Sidhom, E., O'Brien, J. T., Butcher, A. J., Smith, H., Mallucci, G. R., & Underwood, B. R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042021 · Cited by 15
Self-citationFaber, S., & Roepman, R. (2019) · Genes · doi:10.3390/genes10080557 · Cited by 14
Areškevičiūtė, A., Litman, T., Broholm, H., Melchior, L. C., Nielsen, P. R., Green, A., Eriksen, J. O., Smith, C., & Lund, E. L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010140 · Cited by 13
Broad Kinase Inhibition Mitigates Early Neuronal Dysfunction in Tauopathy
Koren, S. A., Hamm, M. J., Cloyd, R., Fontaine, S. N., Chishti, E. A., Lanzillotta, C., Rodriguez-Rivera, J., Ingram, A., Bell, M. C., Escobar, S. M. G., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031186 · Cited by 13
Self-citationAdministration of FK506 from Late Stage of Disease Prolongs Survival of Human Prion-Inoculated Mice
Nakagaki, T., Ishibashi, D., Mori, T., Miyazaki, Y., Takatsuki, H., Tange, H., Taguchi, Y., Satoh, K., Atarashi, R., & Nishida, N. (2020) · Neurotherapeutics · doi:10.1007/s13311-020-00870-1 · Cited by 13
Recent developments in antibody therapeutics against prion disease
Frontzek, K., & Aguzzi, A. (2020) · Emerging Topics in Life Sciences · doi:10.1042/etls20200002 · Cited by 13
The future for treating Creutzfeldt–Jakob disease
Vetrugno, V., Puopolo, M., Cardone, F., Capozzoli, F., Ladogana, A., & Pocchiari, M. (2014) · Expert Opinion on Orphan Drugs · doi:10.1517/21678707.2015.994605 · Cited by 13
Peters, S. L., Déry, M.-A. C., & LeBlanc, A. C. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddv630 · Cited by 13
Miyazaki, Y., Ishikawa, T., Kamatari, Y. O., Nakagaki, T., Takatsuki, H., Ishibashi, D., Kuwata, K., Nishida, N., & Atarashi, R. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1088-7 · Cited by 13
Rozpędek‐Kamińska, W., Pytel, D., Wawrzynkiewicz, A., Siwecka, N., Dziki, A. J., Dziki, Ł. A., Diehl, J. A., & Majsterek, I. (2020) · Current Cancer Drug Targets · doi:10.2174/1568009620666200106114826 · Cited by 13
Tanaka, M., Yamasaki, T., Hasebe, R., Suzuki, A., & Horiuchi, M. (2020) · PLoS ONE · doi:10.1371/journal.pone.0234147 · Cited by 13
Rozpędek‐Kamińska, W., Galita, G., Siwecka, N., Carroll, S. L., Diehl, J. A., Kucharska, E., Pytel, D., & Majsterek, I. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094494 · Cited by 13
Whitechurch, B. C., Welton, J. M., Collins, S. J., & Lawson, V. (2017) · Advances in neurobiology · doi:10.1007/978-3-319-57193-5_13 · Cited by 15
ISR Modulators in Neurological Diseases
Kalinin, A., Zubkova, E., Menshikov, M., & Parfyonova, Y. (2025) · Current Neuropharmacology · doi:10.2174/011570159x361653250213114821 · Cited by 12
When Proteins Go Berserk: The Unfolded Protein Response and ER Stress
Meiseles, D., Arbeli, N., & Dvela‐Levitt, M. (2025) · The Nephron journals/Nephron journals · doi:10.1159/000544971 · Cited by 14
BRI2 ectodomain affects Aβ42 fibrillation and tau truncation in human neuroblastoma cells
Campo, M. D., Oliveira, C. R., Scheper, W., Zwart, R., Korth, C., Müller‐Schiffmann, A., Kostallas, G., Biverstål, H., Presto, J., Johansson, J., et al. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1769-y · Cited by 12
Koss, D. J., & Platt, B. (2017) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000299 · Cited by 12
PERK Inhibition Promotes Post-angioplasty Re-endothelialization via Modulating SMC Phenotype Changes
Wang, B., Zhang, M., Urabe, G., Shirasu, T., Guo, L., & Kent, K. C. (2020) · Journal of Surgical Research · doi:10.1016/j.jss.2020.05.070 · Cited by 12
He, Z., Song, J., Li, X., Li, X., Zhu, H., Wu, C., Xiao, W. H., Du, X., Ni, J., Li, N., et al. (2021) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-021-01874-8 · Cited by 12
Silveira, D. B., Américo, M. F., Flores, N. P., Terenzi, H. F., & Pinto, A. R. (2022) · Cell Biochemistry and Function · doi:10.1002/cbf.3685 · Cited by 12
Wang, L., Pan, Y., Yang, F., Guo, X., Peng, J., Wang, X., Fang, Y., Chen, J., Yi, X., Cao, H., et al. (2022) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2022.109981 · Cited by 12
Identification of anti-prion drugs and targets using toxicity-based assays
Mercer, R. C. C., & Harris, D. A. (2019) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2018.12.005 · Cited by 11
Adipose-derived mesenchymal stromal cells decrease prion-induced glial inflammation in vitro
Hay, A. J. D., Murphy, T. J., Popichak, K. A., Zabel, M. D., & Moreno, J. A. (2022) · Scientific Reports · doi:10.1038/s41598-022-26628-7 · Cited by 12
Self-citationEndoplasmic reticulum stress and ubiquitin-proteasome system impairment in natural scrapie
Lozada-Ortiz, J. P., Betancor, M., Lázaro, S. P., Bolea, R., Badiola, J. J., & Otero, A. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1175364 · Cited by 12
Capone, V., Clemente, E., Restelli, E., Campli, A. D., Sperduti, S., Ornaghi, F., Pietrangelo, L., Protasi, F., Chiesa, R., & Sallese, M. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.07.003 · Cited by 11
Combes, R. D., & Balls, M. (2014) · Alternatives to Laboratory Animals · doi:10.1177/026119291404200206 · Cited by 11
(off)Targeting UPR signaling: the race toward intervening ER proteostasis
Pérez-Arancibia, R., Rivas, A., & Hetz, C. A. (2017) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2018.1420169 · Cited by 11
Chen, X., Zhao, Z., Yao, X., Wei, Y. J., Li, X., Chen, B., & Sun, H. (2026) · Biochemical Pharmacology · doi:10.1016/j.bcp.2026.118218 · Cited by 10
Moon, J.-H., Hong, J.-M., & Park, S. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/5572129 · Cited by 11
Ohri, S. S., Andres, K. R., Howard, R. M., Brown, B. L., Forston, M. D., Hetman, M., & Whittemore, S. R. (2022) · Journal of Neurotrauma · doi:10.1089/neu.2022.0177 · Cited by 11
Brady, R. D., Bird, S., Sun, M., Yamakawa, G. R., Major, B. P., Mychasiuk, R., O'Brien, T. J., McDonald, S. J., & Shultz, S. R. (2021) · Neurotrauma Reports · doi:10.1089/neur.2021.0001 · Cited by 10
A Pipeline for Natural Small Molecule Inhibitors of Endoplasmic Reticulum Stress
da Silva, D. C., Valentão, P., Andrade, P. B., & Pereira, D. M. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.956154 · Cited by 10
Metadata
- Authors
- Moreno, J. A., Halliday, M., Molloy, C., Radford, H., Verity, N., Axten, J. M., Ortori, C. A., Willis, A. E., Fischer, P. M., Barrett, D. A., & Mallucci, G. R.
- Affiliations
- University of Leicester (GB)
- GlaxoSmithKline (United States) (US)
- University of Nottingham (GB)
- Corresponding author
- Mallucci, Giovanna R.
- ORCID
- Venue
- Science Translational Medicine
- Published
- 2013-10-09
- Volume
- 5
- Issue
- 206
- Pages
- 206ra138-206ra138
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- OpenAlex
- W2010375635
- Cited by
- 589
- References
- 29
- Citations by year
- 2026: 22 · 2025: 27 · 2024: 21 · 2023: 29 · 2022: 32 · 2021: 42 · 2020: 59 · 2019: 46 · 2018: 54 · 2017: 72 · 2016: 54 · 2015: 58 · 2014: 58 · 2013: 13
- FWCI
- 27.31
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science Translational Medicine (publishedVersion)
- PubMed (publishedVersion)
- Leicester Research Archive (University of Leicester) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Prion Diseases and Protein Misfolding
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Endoplasmic Reticulum Stress and Disease
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- prion disease, unfolded protein response, protein synthesis inhibition, neurodegeneration, oral drug therapy, neuroprotection, prion replication, synaptic failure, neurodegenerative disease treatment
- MeSH terms
- Adenine, Administration, Oral, Animals, Blood-Brain Barrier, Brain, Indoles, Nerve Degeneration, Phosphorylation, Prions, Synapses, Protein Biosynthesis, Eukaryotic Initiation Factor-2, Prion Diseases, Neuroprotective Agents, eIF-2 Kinase, Mice, Unfolded Protein Response
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review